A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Vassilis E KoulouliasLambros J Vlahos

Abstract

To investigate the cytoprotective effect of intrarectal amifostine administration on acute radiation-induced rectal toxicity. 67 patients with T1b-2 N0 M0 prostate cancer were randomized to receive amifostine intrarectally (group A, n = 33) or not (group B, n = 34) before irradiation. Therapy was delivered using a four-field technique with three-dimensional conformal planning. In group A, 1,500 mg amifostine was administered intrarectally as an aqueous solution in a 40-ml enema. Two different toxicity scales were used: EORTC/RTOG rectal and urologic toxicity criteria along with a Subjective-RectoSigmoid (S-RS) scale based on the endoscopic terminology of the World Organization for Digestive Endoscopy. Objective measurements with rectosigmoidoscopy were performed at baseline and 1-2 days after the completion of radiotherapy. The area under curve for the time course of mucositis (RTOG criteria) during irradiation represented the mucositis index (MI). Intrarectal amifostine was feasible and well tolerated without any systemic or local side effects. According to the RTOG toxicity scale, five out of 33 patients showed grade 1 mucositis in group A versus 15 out of 34 patients with grade 1/2 in group B (p = 0.026). Mean rectal MI was ...Continue Reading

Citations

Mar 13, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·A RazzaghdoustB Mofid
Jan 19, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Hans GeinitzFrank B Zimmermann
Sep 19, 2008·Expert Opinion on Drug Metabolism & Toxicology·Loren K Mell, Benjamin Movsas
Jul 27, 2010·International Journal of Radiation Oncology, Biology, Physics·Te VuongSlobodan Devic
Jan 2, 2010·Cancer Treatment Reviews·Piotr Winczura, Jacek Jassem
Apr 4, 2006·Hematology/oncology Clinics of North America·C T ThomasH Elsaleh
Jul 2, 2015·Clinical Oncology : a Journal of the Royal College of Radiologists·M T W TeoC F Donnellan
Jun 14, 2008·The Journal of Pharmacy and Pharmacology·Natalie P Praetorius, Tarun K Mandal
May 30, 2006·International Journal of Radiation Oncology, Biology, Physics·Anurag K SinghC Norman Coleman
May 18, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean BourhisJean Pierre Pignon
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martee L HensleyLynn M Schuchter
May 9, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vassilis E Kouloulias, John R Kouvaris
Jan 24, 2018·The Cochrane Database of Systematic Reviews·Theresa A LawrieH Jervoise N Andreyev
Feb 11, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Lorenzo FuccioAlessandra Guido
Jul 3, 2007·The Oncologist·John R KouvarisLampros J Vlahos
May 28, 2021·Frontiers in Oncology·Marike W van GisbergenLudwig J Dubois

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.